Who owns LENZ?
Institutional ownership of LENZ Therapeutics Inc. from Form 13F, Q2 2026
144 institutional managers reported holding LENZ Therapeutics Inc. (LENZ) in Form 13F filings for Q2 2026, with 34,719,188 shares worth $197M. The largest reported holder was Ra Capital Management, L.p. Managers that filed both quarters added a net 1,592,689 shares (+4.8%). 29 opened new positions and 27 sold out.
- Funds holding
- 144
- Value held
- $197M
- New / sold out
- 29 / 27
- Net shares, same filers
- +4.8%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of LENZ
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Ra Capital Management, L.p. | $23.7M | 12.0% | 4,178,823 | Unchanged |
| Alpha Wave Global, LP | $20.5M | 10.4% | 3,612,211 | Unchanged |
| FMR LLC | $20.2M | 10.3% | 3,558,905 | Trimmed |
| Versant Venture Management, LLC | $15.1M | 7.7% | 2,656,888 | Unchanged |
| BlackRock, Inc. | $13.0M | 6.6% | 2,292,121 | Added |
| Squarepoint Ops LLC | $9.9M | 5.0% | 1,747,096 | Added |
| Aberdeen Group plc | $8.8M | 4.5% | 1,547,883 | Added |
| Millennium Management LLC | $8.6M | 4.3% | 1,508,478 | Added |
| Vanguard Capital Management LLC | $6.2M | 3.2% | 1,097,755 | Added |
| 72 Investment Holdings, LLC | $5.8M | 2.9% | 1,017,751 | Unchanged |
| Blue Owl Capital Holdings LP | $4.3M | 2.2% | 756,722 | Added |
| C WorldWide Group Holding A/S | $4.0M | 2.0% | 700,000 | Unchanged |
| Geode Capital Management, LLC | $3.2M | 1.6% | 564,662 | Added |
| Trexquant Investment LP | $2.8M | 1.4% | 497,526 | Added |
| Marshall Wace, LLP | $2.8M | 1.4% | 493,099 | Added |
| Qube Research & Technologies Ltd | $2.7M | 1.4% | 482,195 | New |
| Morgan Stanley | $2.7M | 1.4% | 472,995 | Trimmed |
| Primecap Management Co | $2.7M | 1.4% | 472,200 | Unchanged |
| Tang Capital Management LLC | $2.6M | 1.3% | 451,114 | Unchanged |
| Alyeska Investment Group, L.P. | $2.5M | 1.3% | 438,882 | Trimmed |
| State Street Corp | $2.3M | 1.2% | 406,674 | Added |
| Citadel Advisors LLC | $2.1M | 1.0% | 363,229 | New |
| Two Sigma Investments, LP | $1.6M | 0.8% | 285,584 | Trimmed |
| Rock Springs Capital Management LP | $1.5M | 0.7% | 257,460 | Unchanged |
| Bank of America Corp | $1.5M | 0.7% | 255,410 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 34,719,188 LENZ shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Millennium Management LLC Added+$3.6M
- Qube Research & Technologies Ltd New+$2.7M
- Aberdeen Group plc Added+$2.2M
- Citadel Advisors LLC New+$2.1M
- Marshall Wace, LLP Added+$1.9M
- BlackRock, Inc. Added+$1.8M
- Trexquant Investment LP Added+$1.6M
- Blue Owl Capital Holdings LP Added+$1.4M
- Squarepoint Ops LLC Added+$1.4M
- Jefferies Financial Group Inc. New+$1.1M
Biggest sellers in Q2 2026
- Franklin Resources Inc Sold out-$10.1M
- Silvercrest Asset Management Group LLC Sold out-$2.6M
- Bank of America Corp Trimmed-$1.7M
- HRT Financial LP Sold out-$1.3M
- Two Sigma Investments, LP Trimmed-$1.2M
- Susquehanna International Group, LLP Sold out-$1.0M
- Morgan Stanley Trimmed-$999K
- Debussy Capital Management LP Sold out-$586K
- Barclays PLC Trimmed-$575K
- Jacobs Levy Equity Management, Inc Trimmed-$573K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $28.6M and sold $26.6M; 59 added and 34 trimmed.
Schedule 13D and 13G filings on LENZ
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-04BML Investment Partners, L.P. SCHEDULE 13G filed by LENZ Therapeutics Inc.Schedule 13G
- 2026-06-26MILLENNIUM MANAGEMENT LLC SCHEDULE 13G filed by LENZ Therapeutics Inc.Schedule 13G
- 2026-04-27BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2026-04-08Squarepoint Ops LLC SCHEDULE 13G filed by LENZ Therapeutics Inc.Schedule 13G
- 2025-11-07FMR LLC SCHEDULE 13G filed by LENZ Therapeutics Inc.Schedule 13G
- 2025-10-17BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-03-27Paradigm Biocapital Advisors LP SCHEDULE 13G filed by LENZ Therapeutics Inc.Schedule 13G
Questions about LENZ ownership
- Who owns LENZ stock?
- 144 institutional investment managers reported LENZ positions in their Form 13F filings for Q2 2026, holding 34,719,188 shares worth $197M in total. Ra Capital Management, L.p. reported the largest position.
- Are funds buying or selling LENZ?
- In Q2 2026, 29 managers opened new LENZ positions, 59 added, 34 trimmed and 27 sold out. Managers that filed in both quarters added a net 1,592,689 shares.
- How current is this LENZ institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to LENZ by CUSIP. Options are left out. LENZ news and filings · LENZ insider trades · Top funds